Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinomaMakoto Chuma, Shin Maeda, Yoshitake Arase et al.|Hepatology International|2024Cited by 11
A Novel PI3K-driven Mouse Model of Intrahepatic Cholangiocarcinoma and Synergistic Antitumor Effects of Combined PI3K and WEE1 InhibitionHiromi Tsuchiya, Shin Maeda, Makoto Sugimori et al.|Research Square|2026Cited by 0